ANOMALY WEALTHMutual Fund Intelligence HoldingsSep 2026 Trade Intelligence ↗
FUNCTION CODESType a code in the search bar and press Enter
TOPWhat funds are buyingBUYMost bought stocks (₹)SELLMost sold stocks (₹)SCRNStock screenerSECTSectorsINSOwnership & liquidity insightsFLOWMoney flowsHEATFlow heatmapNFONew fund offersSIPSIP trendsFIIFII & DII dailyCATCategoriesFUNDFund explorerCMPCompare fundsAMCFund housesSHRFund-house market shareXRAYPortfolio X-rayMONMonthly reportDIGWhat changedRESResearch: what held upDATAData status
KEYBOARDAnywhere outside a text box

/Command bar

?This help

ghHome

gmMonthly report

gaWhat funds are buying

gsStocks

gfFunds

glMoney flows

gcCategories

goFund houses

gxPortfolio X-ray

grResearch

Economic portfolio

ICICI Prudential Nifty Pharma Index Fund

ICICI ICICI Prudential Mutual Fund Jul 2026 — Sep 2026 3 months

Data periodFund holdingsSep 2026NSE prices23 Oct 2026Data status →

Indian listed equity disclosed₹163 CrAt NSE closes, Sep 2026
Companies held2020 with an NSE price
Top 10 holdings78.2%Of the equity shown here
Largest holding19.5%Sun Pharmaceutical Industries Limited
12-month turnover—Not enough comparable months

Days to sell half: 0.2 — selling half of every holding at 20% of each stock’s usual daily NSE trading, the time to get through 90% of the portfolio (Sep 2026). Quick to unwind on normal volumes. Small-cap comparison →

Shares of this fund’s disclosed Indian listed equity, valued at official NSE closing prices. Cash, debt, derivatives and overseas holdings are not included, so for a hybrid or debt fund these are shares of its equity part only. Not performance, and not a recommendation.

How concentrated it has been

3 priced months, Jul 2026 to Sep 2026 · at each month’s NSE closes

Top 10 holdings, share of equity

78.2% now · highest 79.1%, lowest 78.2%

Companies held

20 now · largest single holding 19.5% of equity

Sector mix

Share of the equity shown · NSE industry

Funds most like this one

Overlap of disclosed equity · the smaller share of each company both hold, added up

  1. Nippon India Nifty Pharma ETFNippon India · 20 shared100.0%
  2. ICICI Prudential Nifty Healthcare ETFICICI Prudential · 16 shared81.1%
  3. DSP Nifty Healthcare ETFDSP · 16 shared81.1%
  4. Axis NIFTY Healthcare ETFAxis · 16 shared81.1%
  5. DSP Nifty Healthcare Index FundDSP · 16 shared81.1%
  6. ADITYA BIRLA SUN LIFE NIFTY HEALTHCARE ETFAditya Birla Sun Life · 16 shared81.1%
  7. EODWHFEdelweiss · 17 shared77.4%
  8. Mirae Asset Nifty 500 Healthcare ETFMirae Asset · 20 shared69.0%

Select one to see exactly what the two funds share. Index funds and ETFs tracking the same index overlap almost completely.

What changed in Sep 2026

This portfolio’s consecutive disclosures · evidenced adjustments applied

New positions 0 Companies added
Complete exits 0 Companies sold out
Increases 20 More shares than last month
Reductions 0 Fewer shares than last month

Share quantities, not market values or cash flows.

Holdings by value

Sep 2026 · largest 100 · share of the equity shown

Download all (CSV)
CompanySectorSizeShare of equityValueShares heldHeld since
Sun Pharmaceutical Industries Limited Healthcare Large Cap 19.51% 31.81 Cr 0.02 Cr by Jul 2026 (3 mo+)
Divi's Laboratories Limited Healthcare Large Cap 11.98% 19.52 Cr 21,013 by Jul 2026 (3 mo+)
Laurus Labs Limited Healthcare Mid Cap 7.82% 12.75 Cr 64,400 by Jul 2026 (3 mo+)
Cipla Limited Healthcare Large Cap 7.68% 12.52 Cr 93,053 by Jul 2026 (3 mo+)
Dr. Reddy's Laboratories Limited Healthcare Large Cap 7.63% 12.43 Cr 0.01 Cr by Jul 2026 (3 mo+)
Torrent Pharmaceuticals Limited Healthcare Large Cap 7.17% 11.68 Cr 24,332 by Jul 2026 (3 mo+)
Lupin Limited Healthcare Mid Cap 5.00% 8.15 Cr 40,165 by Jul 2026 (3 mo+)
Aurobindo Pharma Limited Healthcare Mid Cap 4.69% 7.64 Cr 45,698 by Jul 2026 (3 mo+)
Glenmark Pharmaceuticals Limited Healthcare Mid Cap 3.57% 5.81 Cr 24,895 by Jul 2026 (3 mo+)
Alkem Laboratories Limited Healthcare Mid Cap 3.16% 5.15 Cr 9,970 by Jul 2026 (3 mo+)
Zydus Lifesciences Limited Healthcare Mid Cap 2.92% 4.76 Cr 40,975 by Jul 2026 (3 mo+)
Mankind Pharma Limited Healthcare Mid Cap 2.88% 4.69 Cr 18,737 by Jul 2026 (3 mo+)
IPCA Laboratories Limited Healthcare Mid Cap 2.72% 4.43 Cr 22,971 by Jul 2026 (3 mo+)
Biocon Limited Healthcare Mid Cap 2.62% 4.27 Cr 0.01 Cr by Jul 2026 (3 mo+)
Gland Pharma Limited Healthcare Small Cap 2.34% 3.82 Cr 13,178 by Jul 2026 (3 mo+)
Sai Life Sciences Limited Healthcare Small Cap 2.14% 3.49 Cr 22,870 by Jul 2026 (3 mo+)
Wockhardt Limited Healthcare Small Cap 1.77% 2.89 Cr 13,659 by Jul 2026 (3 mo+)
Ajanta Pharma Limited Healthcare Small Cap 1.67% 2.73 Cr 7,537 by Jul 2026 (3 mo+)
Abbott India Limited Healthcare Mid Cap 1.43% 2.34 Cr 861 by Jul 2026 (3 mo+)
Piramal Pharma Limited Healthcare Small Cap 1.30% 2.12 Cr 0.01 Cr by Jul 2026 (3 mo+)

Half of its current holdings have been held for 3 disclosed months or more without a break. “By” means held in the first month we have for this fund, so possibly for longer. Counted over this fund’s own monthly disclosures; a merger (e.g. HDFC into HDFC Bank, July 2023) starts a new run for the surviving company.

Recent position changes

Latest 100 company-month records · evidenced adjustments applied

CompanyMonthActivityAdjusted change
Sun Pharmaceutical Industries Limited Sep 2026 ▲ Increasing +10,976
Dr. Reddy's Laboratories Limited Sep 2026 ▲ Increasing +6,371
Piramal Pharma Limited Sep 2026 ▲ Increasing +6,324
Cipla Limited Sep 2026 ▲ Increasing +5,853
Biocon Limited Sep 2026 ▲ Increasing +4,670
Laurus Labs Limited Sep 2026 ▲ Increasing +4,108
Aurobindo Pharma Limited Sep 2026 ▲ Increasing +2,807
Lupin Limited Sep 2026 ▲ Increasing +2,534
Zydus Lifesciences Limited Sep 2026 ▲ Increasing +2,207
Torrent Pharmaceuticals Limited Sep 2026 ▲ Increasing +1,608
Glenmark Pharmaceuticals Limited Sep 2026 ▲ Increasing +1,570
Sai Life Sciences Limited Sep 2026 ▲ Increasing +1,496
IPCA Laboratories Limited Sep 2026 ▲ Increasing +1,453
Divi's Laboratories Limited Sep 2026 ▲ Increasing +1,325
Mankind Pharma Limited Sep 2026 ▲ Increasing +1,203
Ajanta Pharma Limited Sep 2026 ▲ Increasing +1,021
Alkem Laboratories Limited Sep 2026 ▲ Increasing +914
Wockhardt Limited Sep 2026 ▲ Increasing +871
Gland Pharma Limited Sep 2026 ▲ Increasing +837
Abbott India Limited Sep 2026 ▲ Increasing +66
Sun Pharmaceutical Industries Limited Aug 2026 ▲ Increasing +5,542
Biocon Limited Aug 2026 ▲ Increasing +3,734
Piramal Pharma Limited Aug 2026 ▲ Increasing +3,253
Dr. Reddy's Laboratories Limited Aug 2026 ▲ Increasing +3,189
Cipla Limited Aug 2026 ▲ Increasing +2,941
Laurus Labs Limited Aug 2026 ▲ Increasing +2,031
Aurobindo Pharma Limited Aug 2026 ▲ Increasing +1,444
Zydus Lifesciences Limited Aug 2026 ▲ Increasing +1,306
Lupin Limited Aug 2026 ▲ Increasing +1,267
Glenmark Pharmaceuticals Limited Aug 2026 ▲ Increasing +781
Torrent Pharmaceuticals Limited Aug 2026 ▲ Increasing +762
IPCA Laboratories Limited Aug 2026 ▲ Increasing +720
Sai Life Sciences Limited Aug 2026 ▲ Increasing +716
Divi's Laboratories Limited Aug 2026 ▲ Increasing +661
Mankind Pharma Limited Aug 2026 ▲ Increasing +584
Wockhardt Limited Aug 2026 ▲ Increasing +426
Gland Pharma Limited Aug 2026 ▲ Increasing +414
Alkem Laboratories Limited Aug 2026 ▲ Increasing +297
Ajanta Pharma Limited Aug 2026 ▲ Increasing +214
Abbott India Limited Aug 2026 ▲ Increasing +18

Changes compare consecutive month-end disclosures for this portfolio only.